Latest minority interest for ADMA: $0.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Adma Biologics (ADMA) currently reports a minority interest of $0 as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Adma Biologics's minority interest history and peer comparisons.
Adma Biologics's minority interest changed from $0 to $0 (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Adma Biologics reported $0 in minority interest as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current minority interest of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Adma Biologics, and consider following ADMA for alerts when major investors trade the stock.
Adma Biologics is classified in the Healthcare sector. On minority interest, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ADMA with unrelated industries.